Sort   by:  
 Page size 
UnknownSimulation-based training and assessment of mobile pre-hospital SARS-CoV-2 diagnostic teams in Styria, Austria.
Not available
S-EPMC7373634 | biostudies-literature
UnknownCOVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
Not available
S-EPMC10787678 | biostudies-literature
UnknownSpotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Not available
S-EPMC5933337 | biostudies-literature
UnknownAspergillus fumigatus and Its Allergenic Ribotoxin Asp f I: Old Enemies but New Opportunities for Urine-Based Detection of Invasive Pulmonary Aspergillosis Using Lateral-Flow Technology.
Not available
S-EPMC7823411 | biostudies-literature
UnknownPerformance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
Not available
S-EPMC8492156 | biostudies-literature
UnknownChemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?
Not available
S-EPMC4767967 | biostudies-literature
UnknownMycobiome analyses of critically ill COVID-19 patients.
Not available
S-EPMC11792475 | biostudies-literature
UnknownUrine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.
Not available
S-EPMC4767980 | biostudies-literature
UnknownSoluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Not available
S-EPMC8410930 | biostudies-literature
UnknownUsing Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.
Not available
S-EPMC6687868 | biostudies-literature
Sort   by:  
 Page size